Your browser doesn't support javascript.
loading
Severe asthma care trajectories: the French RAMSES cohort.
Perotin, Jeanne-Marie; Gauquelin, Lisa; Just, Nicolas; Devouassoux, Gilles; Chenivesse, Cécile; Bourdin, Arnaud; Garcia, Gilles; Saint Raymond, Christel; Boudjemaa, Amel; Bonniaud, Philippe; Chanez, Pascal; Barnig, Cindy; Beurnier, Antoine; Maurer, Cyril; Freymond, Nathalie; Didi, Toufik; Tcherakian, Colas; Russier, Maud; Drucbert, Mélanie; Guillo, Sylvie; Estellat, Candice; Taillé, Camille.
Afiliação
  • Perotin JM; Department of Respiratory Diseases, University Hospital of Reims, Reims, France.
  • Gauquelin L; University of Reims Champagne-Ardenne, Inserm UMR-S 1250, SFR Cap-Santé, Reims, France.
  • Just N; CRISALIS/F-CRIN INSERM Network, France.
  • Devouassoux G; AP-HP, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
  • Chenivesse C; Respiratory Diseases Department, Victor Provo Hospital, Roubaix, France.
  • Bourdin A; CRISALIS/F-CRIN INSERM Network, France.
  • Garcia G; Service de Pneumologie, CIERA, Hôpital de la Croix Rousse, GHN, HCL, VIRPATH, Université Claude Bernard Lyon 1, Lyon, France.
  • Saint Raymond C; University of Reims Champagne-Ardenne, Inserm UMR-S 1250, SFR Cap-Santé, Reims, France.
  • Boudjemaa A; Université de Lille, CNRS, Inserm, CHU Lille, U1019 - UMR 9017 - Center for Infection and Immunity of Lille, Lille, France.
  • Bonniaud P; Université de Montpellier, PhyMedExp, INSERM, CNRS, Montpellier, France.
  • Chanez P; Service de Pneumologie, Hôpital Privé d'Antony, Antony, France.
  • Barnig C; Service de Pneumologie, CHU Grenoble Alpes, Grenoble, France.
  • Beurnier A; Service de Pneumologie, CHI de Créteil, Créteil, France.
  • Maurer C; University of Reims Champagne-Ardenne, Inserm UMR-S 1250, SFR Cap-Santé, Reims, France.
  • Freymond N; Department of Respiratory Diseases and Intensive Care, Dijon-Bourgogne University Hospital, Dijon, France.
  • Didi T; University of Burgundy, Inserm UMR1231, Dijon, France.
  • Tcherakian C; Aix-Marseille Université, INSERM, INRAE, C2VN, Marseille, France.
  • Russier M; AP-HM, Hôpital Nord, Clinique des Bronches, de l'Allergie et du Sommeil, Marseille, France.
  • Drucbert M; University of Reims Champagne-Ardenne, Inserm UMR-S 1250, SFR Cap-Santé, Reims, France.
  • Guillo S; Université de Franche-Comté, CHU Besançon, EFS, INSERM, UMR RIGHT, Besançon, France.
  • Estellat C; Department of Physiology - Functional Explorations, bi-site Hôpital Bicêtre (Le Kremlin-Bicêtre) and Ambroise Paré (Boulogne-Billancourt), DMU 5 Thorinno, AP-HP, Université Paris-Saclay, INSERM UMR_S 999, Paris, France.
  • Taillé C; Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France.
ERJ Open Res ; 10(2)2024 Mar.
Article em En | MEDLINE | ID: mdl-38651091
ABSTRACT

Background:

The French RAMSES study is an observational prospective multicentre real-life cohort including severe asthmatic subjects. The objective of the study was to compare the characteristics of patients, in terms of phenotype and asthma care trajectories, between those managed by tertiary referral centres (TRCs) or secondary care centres (SCCs).

Methods:

Patients were prospectively recruited and enrolled for a 5-year follow-up. Patients' characteristics were analysed at inclusion and compared between TRCs and SCCs.

Results:

52 centres (24 TRCs and 28 SCCs) included 2046 patients 1502 (73.4%) were included by a TRC and 544 (26.6%) by a SCC. Patients were mainly women (62%), 53±15 years old, 67% with Asthma Control Test <20; at inclusion, 14% received oral corticosteroids (OCS) and 66% biologics. Compared with the SCC group, the TRC group had more frequent comorbidities and lower blood eosinophil counts (262 versus 340 mm-3; p=0.0036). OCS and biologics use did not differ between groups, but patients in the TRC group benefited more frequently from an educational programme (26% versus 18%; p=0.0008) and received more frequently two or more sequential lines of biologics (33% versus 24%; p=0.0105). In-depth investigations were more frequently performed in the TRC group (allergy tests 74% versus 62%; p<0.0001; exhaled nitric oxide fraction 56% versus 21%; p<0.0001; induced sputum 6% versus 3%; p=0.0390).

Conclusions:

Phenotypes and care trajectories differed in the RAMSES cohort between SCCs and TRCs, probably related to different levels of asthma severity and differences in medical resources and practices among centres. This highlights the need for standardisation of severe asthma care.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article